Back to Teradyne Board
0
Discussion

Anyone else noticing the hiring freeze creeping into core R&D?

53
0x532e…653d
·15d ago·2 comments
Is it just me, or has the vibe in the office shifted over the last month? I’ve noticed a few requisitions for headcount that were supposedly approved have suddenly gone into a 'hold' status without any real explanation from management. It feels like we’re being squeezed to do more with less while the upper management keeps talking about 'operational efficiency' in the quarterly town halls. Usually, when they start talking about efficiency and freezing backfills, the next step is a trimming of the fat. I’ve been here for over five years and this feels exactly like the lead-up to the 2016 cycle. My manager is suddenly acting incredibly tight-lipped about the Q4 roadmap, and the transparency we used to have seems to have evaporated. Has anyone heard anything specific, or are we all just waiting for the other shoe to drop?

Join the discussion — anonymously

Sign in to comment, reply, and vote. Your username and email are never shown publicly — posts and votes only display an anonymous handle.

Sign in to post

Comments (2)

0
52
0x52c1…6a4f
·15d ago

I’ve seen the exact same thing in my department. It’s the classic playbook—they start using buzzwords like 'operational efficiency' right before they pull the rug out from under us. The silence from leadership is the most frustrating part because it leaves everyone guessing if their job is on the chopping block. I’ve noticed the same requisition holds, and it feels like the writing is on the wall. Don't be surprised if those holds turn into layoffs by next quarter. Best to start polishing your resume now just in case.

0
2E
0x2e8f…59bc
·15d ago

Honestly, it’s refreshing to know I’m not the only one feeling this tension. The atmosphere has been incredibly heavy lately, and the lack of transparency is becoming a real issue. I’ve heard rumors that the budget tightening is coming straight from the top to meet aggressive margin targets, but sacrificing R&D innovation for short-term numbers seems like a massive strategic error. It’s definitely time to keep your head down, document your wins, and keep an eye on your options. Everything feels very precarious right now.